3 research outputs found
Microstructure and Interface Characterization of CP-Mg and AZ91 Composite Alloys
Commercial pure magnesium and magnesium-9 aluminum-1 zinc (CP-Mg and AZ91) and their composites were prepared by using flux cover. Magnesium composite alloys containing Al2O3 or SiC particulates of different volume fractions (7-15% Vf) were successfully produced using stir-casting technique. The fabrication processes and controlling parameters of Mg composites produced by this technique were investigated. AZ91 and its composite alloys were solution treated at 420 °C for 20 hrs and aged at 170 °C for 30 hrs. Addition of 2 wt.% mish metal (MM) was also studied in this work. Addition of either reinforcements or MM to these alloys resulted to a considerable grain refinement of the matrix alloys and the degree of refinement increases as the volume fractions of reinforcement increased. The microstructure was investigated by optical microscope. The interface reaction was analyzed using EDS and X-ray diffraction. The results of the X-ray diffraction reveal the presence of MgO and Mg2Si in the CP-Mg besides Mg17Al12 in the AZ91 alloy
International Nosocomial Infection Control Consortium report, data summary of 50 countries for 2010-2015: Device-associated module
â˘We report INICC device-associated module data of 50 countries from 2010-2015.â˘We collected prospective data from 861,284 patients in 703 ICUs for 3,506,562 days.â˘DA-HAI rates and bacterial resistance were higher in the INICC ICUs than in CDC-NHSN's.â˘Device utilization ratio in the INICC ICUs was similar to CDC-NHSN's.
Background: We report the results of International Nosocomial Infection Control Consortium (INICC) surveillance study from January 2010-December 2015 in 703 intensive care units (ICUs) in Latin America, Europe, Eastern Mediterranean, Southeast Asia, and Western Pacific.
Methods: During the 6-year study period, using Centers for Disease Control and Prevention National Healthcare Safety Network (CDC-NHSN) definitions for device-associated health care-associated infection (DA-HAI), we collected prospective data from 861,284 patients hospitalized in INICC hospital ICUs for an aggregate of 3,506,562 days.
Results: Although device use in INICC ICUs was similar to that reported from CDC-NHSN ICUs, DA-HAI rates were higher in the INICC ICUs: in the INICC medical-surgical ICUs, the pooled rate of central line-associated bloodstream infection, 4.1 per 1,000 central line-days, was nearly 5-fold higher than the 0.8 per 1,000 central line-days reported from comparable US ICUs, the overall rate of ventilator-associated pneumonia was also higher, 13.1 versus 0.9 per 1,000 ventilator-days, as was the rate of catheter-associated urinary tract infection, 5.07 versus 1.7 per 1,000 catheter-days. From blood cultures samples, frequencies of resistance of Pseudomonas isolates to amikacin (29.87% vs 10%) and to imipenem (44.3% vs 26.1%), and of Klebsiella pneumoniae isolates to ceftazidime (73.2% vs 28.8%) and to imipenem (43.27% vs 12.8%) were also higher in the INICC ICUs compared with CDC-NHSN ICUs.
Conclusions: Although DA-HAIs in INICC ICU patients continue to be higher than the rates reported in CDC-NSHN ICUs representing the developed world, we have observed a significant trend toward the reduction of DA-HAI rates in INICC ICUs as shown in each international report. It is INICC's main goal to continue facilitating education, training, and basic and cost-effective tools and resources, such as standardized forms and an online platform, to tackle this problem effectively and systematically